LGALS9 and hepatocellular carcinoma: High galectin-9 expression was significantly correlated with better OS in the patients with HCC (HR = 0.56, 95% CI = 0.44–0.71, p < 0.001) without significant heterogeneity (I2 = 3.7%, p = 0.393).